NEW YORK, April 25  - Despite a flurry of new collaborations with users of its microbead technology, Lynx Therapeutics reported Wednesday nearly flat first-quarter revenues.

Lynx’s revenues increased slightly to $3.4 million, from $3.0 million for the first quarter of 2000, stemming from service and access fees to Lynx’s technology. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.